These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21270194)

  • 1. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
    Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
    Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
    Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
    Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
    Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
    Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
    Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
    Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of HbA1c combined FPG on screening diabetes in health check-up.
    Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
    Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
    Inoue K; Matsumoto M; Akimoto K
    Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
    Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
    Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.
    Massin P; Lange C; Tichet J; Vol S; Erginay A; Cailleau M; Eschwège E; Balkau B;
    Arch Ophthalmol; 2011 Feb; 129(2):188-95. PubMed ID: 21320965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the same clinical risk factors relevant for incident diabetes defined by treatment, fasting plasma glucose, and HbA1c?
    Balkau B; Soulimane S; Lange C; Gautier A; Tichet J; Vol S;
    Diabetes Care; 2011 Apr; 34(4):957-9. PubMed ID: 21346181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
    Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
    Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus.
    Tekumit H; Cenal AR; Polat A; Uzun K; Tataroglu C; Akinci E
    Ann Thorac Surg; 2010 May; 89(5):1482-7. PubMed ID: 20417764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose.
    Tatsch E; Bochi GV; Piva SJ; Pereira RS; Kober H; De Carvalho JA; Sangoi MB; Duarte MM; Moresco RN
    Clin Lab; 2012; 58(3-4):347-50. PubMed ID: 22582512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.